Inozyme Pharma Inc. (INZY)
Inozyme Pharma Max Pain By Strike
INZY trades at $4, 60.0% above the near-term max pain of $2.5 expiring Nov 21, 2025 (72 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($2.5-$5.5), reflecting growing call interest at higher strikes. Key magnetic zone at 3 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Inozyme Pharma Max Pain By Expiry
Max pain for INZY shows an upward trend from 2.5 to 5.5, suggesting bullish positioning in longer-dated options. The 92% spread signals divergent expectations across timeframes. Most levels below 4 may cap rallies. Strong magnetic level at 3 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Nov 21, 2025 | 2.5 | -1.50 (-37.50%) |
| Dec 19, 2025 | 2.5 | -1.50 (-37.50%) |
| Jan 16, 2026 | 5.5 | 1.50 (37.50%) |
| Feb 20, 2026 | 2.5 | -1.50 (-37.50%) |